4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-17-027803
President & CEO bought 50,000 shares at $0.81 ($40,500)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Manor Moshe President & CEO | 2017-05-16 | Purchase | +50,000 | $0.81 | $40,500 | 50,000 | D |
| Open-market purchases · 50,000 sh · avg $0.81 · $40,500 | |||||||
Loading xslF345X03/v467168_4.xml…